Multicenter trial

Content sourced from Wikipedia, licensed under CC BY-SA 3.0.

Multicenter trials are studies conducted at more than one medical center. All centers use the same treatment plan and data rules, and a central team collects and analyzes the data.

Why they are useful:
- They enroll more people faster than a single center.
- They’re important when a treatment’s benefit is small or outcomes are rare, needing a larger group.
- They’re common for late-stage drug testing (Phase III), which compares a new treatment to a standard one.
- They include patients from different places and backgrounds, making results more generalizable.
- They let researchers compare results across centers and study how different populations respond.

A potential drawback:
- Because the participants can be more diverse, detecting a specific effect may require a larger overall sample size.